Bioventus(BVS)
$10.99-0.19 (-1.70%)
BVS
Bioventus financials statements
$10.99
At close:-0.19 (-1.70%)
Want to see BVS full AI Analyst Report?
Bioventus (BVS) Income Statement
230 Followers
Bioventus Income Statement
Last quarter (Q3 2026), Bioventus's total revenue was $142.44M, an increase of 2.73% from the same quarter last year. In Q3, Bioventus's net income was $5.99M. See Bioventus’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| $ 568.09M | $ 573.28M | $ 512.35M | $ 512.12M | $ 430.90M | |
| $ 382.43M | $ 388.23M | $ 328.19M | $ 331.08M | $ 302.71M | |
| $ 323.88M | $ 400.20M | $ 409.92M | $ 498.31M | $ 290.64M | |
| Depreciation and Amortization | $ 47.01M | $ 49.55M | $ 57.37M | $ 55.40M | $ 34.88M |
| $ 99.21M | $ 39.22M | $ -23.07M | $ -121.61M | $ 45.48M | |
| $ 58.55M | $ -11.98M | $ -81.72M | $ -167.23M | $ 12.06M | |
| $ -32.84M | $ -37.15M | $ -39.39M | $ -21.79M | $ -2.57M | |
| $ 25.71M | $ -49.13M | $ -121.11M | $ -189.03M | $ 9.49M | |
| $ 22.73M | $ -33.54M | $ -156.23M | $ -158.70M | $ 19.38M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.34 | $ -0.52 | $ -2.49 | $ -2.59 | $ -0.15 |
| Diluted EPS | $ 0.33 | $ -0.52 | $ -2.49 | $ -2.59 | $ -0.15 |
| Weighted Average Shares Outstanding | 66.62M | 65.36M | 62.65M | 61.39M | 45.47M |
| Weighted Average Shares Outstanding (Diluted) | 68.91M | 65.36M | 62.65M | 61.39M | 45.47M |
Currency in USD
